Macrophage migration inhibitory factor (MIF) is well established as a key cytokine in immuno-
inflammatory diseases such as rheumatoid arthritis. Inflammation is now also recognized as …

Introduction: CD74, also known as the invariant chain, participates in several key processes
of the immune system, including antigen presentation, B-cell differentiation and inflammatory …

Macrophage migration inhibitory factor (MIF) accounts for one of the first cytokine activities to
have been described, and it has emerged recently to be an important regulator of innate and …

Mounting an effective immune response against cancer requires the activation of innate and
adaptive immune cells. Metastatic melanoma is the most aggressive form of skin cancer …

1. Introduction 292. Landmarks in NMR of macromolecules 322.1 Protein structures and
methods development 322.1. 1 Sequential assignment method 322.1. 2 Triple-resonance …

Major histocompatibility complex class II molecules (MHC II) have developed a particular
trafficking pathway, which allows them to load antigenic peptides generated in the …

Introduction: Macrophage migration inhibitory factor (MIF) has emerged as a promising drug
target in diseases including sepsis, rheumatoid arthritis, and cancer. MIF has multiple …

For more than 15 years, the tautomerase active site of macrophage migration inhibitory
factor (MIF) and its catalytic residue Pro1 have been being targeted for the development of …

The list of alleles in the HLA-DRB, HLA-DQA, and HLA-DQB gene loci has grown
enormously since the last listing in this journal 8 years ago. Crystal structure determination …

Since the first Handbook of Cell-Penetrating Peptides was prepared in 2001, the wealth of
new information on the use of these peptides as transport systems has in fact served to …